Physician profile
David D Bush
NPI 1427339472
$906.18
in general payments reported to CMS, 2019-2025
20 companies · $58.99 in 2025
The $58.99 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.87 · 2020: $51.18 · 2021: $131 · 2022: $91.44 · 2023: $342 · 2024: $196 · 2025: $58.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.27 | 2023-2025 | Durysta, Vuity, Alphagan P |
| Sun Pharmaceutical Industries INC. | $123.22 | 2019-2024 | Cequa |
| Bausch & Lomb Americas INC. | $74.41 | 2023-2024 | Vyzulta, Lotemax Sm, Miebo |
| Alcon Vision LLC | $54.49 | 2023-2024 | Argos |
| Biotissue Holdings INC. | $50.81 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.02 | 2020-2021 | |
| Allergan, INC. | $35.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $33.19 | 2022-2023 | |
| Oyster Point Pharma, INC. | $31.46 | 2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $31.10 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $28.06 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $23.75 | 2021 | |
| Mallinckrodt Hospital Products INC. | $21.12 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Glaukos Corporation | $18.36 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Rxsight INC | $16.19 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Eyevance Pharmaceuticals LLC | $14.90 | 2021 | |
| Horizon Therapeutics Plc | $12.82 | 2023 | Tepezza |
| Ocular Therapeutix, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.